Cited by 697Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Plasma triglyceride and coronary heart disease

Open access

Austin, M A·1991·Arteriosclerosis and Thrombosis: A Journal of Vascular Biology

DOI 10.1161/01.atv.11.1.2

Open this paper in CoChat — free account Open PDF

Abstract

Although the literature on epidemiological associations between plasma triglyceride and CHD is not completely consistent, trends do emerge from the studies described here. First, the majority of observational studies demonstrate a significant univariate relation, although the results of case-control and cross-sectional studies are more uniform than those from prospective study designs. In many but not all studies, triglyceride remains a significant predictor of CHD in multivariate statistical analyses after controlling for TC or LDL-C. Perhaps the least consistent result is that the triglyceride association does not persist in some analyses controlling for HDL-C, while in other studies, the association remains significant. Although most studies have been conducted in men, the studies providing data on women, normocholesterolemic subjects, and diabetic subjects have generally found triglyceride to be, at the very least, a univariate risk factor. The results of intervention trials differ considerably, but no such study to date has been specifically designed to evaluate triglyceride-lowering effects on primary prevention of CHD. Important statistical properties must be taken into consideration in evaluating triglyceride as a risk factor for CHD. The large variability of triglyceride measurements and the correlation of triglyceride values with other lipid measures appears to result in the underestimation of the association between triglyceride and disease in multivariate analyses. Finally, individual genetic susceptibility may play an important role in the relation between plasma triglyceride levels and CHD. For example, risk of CHD clearly varies among the well-established familial forms of hypertriglyceridemia. A predominance of small, dense, LDL particles (LDL subclass pattern B) also appears to be a genetic trait associated with both increased risk of MI and increases in plasma triglyceride levels.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.11.1.2

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Self-citation
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
Garcia, M. J., McNamara, P. M., Gordon, T., & Kannell, W. B. (1974) · Diabetes · doi:10.2337/diab.23.2.105 · Cited by 1,608
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., de Faire, U., Dahlén, G. H., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,444
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Self-citation

Flagged first, then by citations

Show all 98 references

Research works printed but not linked: 26

[2]2. National Heart, Lung, and Blood Institute Consensus Development Panel: Treatment of hypertriglyceridemia. JAMA 1984;251:1196-1200
[15]15. factors in relation to acute myocardial infarction. Arteriosclerosis 1981;1:273-279
[30]30. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR: Is the level of serum triglyceride a it,, ot f oo teir olemic" subjects? The Paris Prospective Study. Am J Epidemiol 1986;124:624-632
[29]29. Carlson LA, Böttiger LÈ: Risk factors for ischaemic heart disease in men and women. Acta Med Scand 1985;218:207–211
[32]32. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangiwala S: Triglycerides and coronary heart disease mortality: The Lipid Research Clinics Follow-up Study. Atheroscler Rev (in press)
[34]34. Pocock SJ, Shaper AG, Phillips AN: Concentrations of high density lipoprotein cholesterol, triglyceride and total cholesterol in ischaemic heart disease. Br Med J 1989;298:998–1002
[37]37. Wilson PF: The impact of triglycerides on coronary heart disease: The Framingham Study. Atherosclerosis Rev (in press)
[4]4. Scand Suppl 1973;549:51–59
[46]46. Salel AF, Riggs K, Mason DT, Amsterdam EA, Zelis R: The impdsie rea psie ia p psng factor in coronary artery disease. Am J Med 1974;57:897–903
[50]50. Jenkins PJ, Harper RW, Nestel PJ: Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J 1978;2:388-391
[53]53. Wieland H, Seidel D, Wiegand V, Kreuzer H: Serum lipoproteins and coronary artery disease (CAD). Atherosclerosis 1980;36:269-280
[55]55. Holmes DR Jr, Elveback LR, Frye RL, Kottke BA, Ellefson RD: Association of risk factor variables and coronary artery disease documented with angiography. Circulation 1981;63: 293-299
[58]58. Reardon MF, Nestel PJ, Craig IH, Harper RW: Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985;71:881-888
[64]64. Santen RJ, Willis PW, Fajaris SS: Atherosclerosis in diabetes mellitus: Correlations with lipid levels, adiposity and serum insulin level. Arch Intern Med 1972;130:833–843
[66]66. Janka HU: Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metab Res Suppl Series 1985;15:15-19
[71]71. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-374
[77]77. Kelsey J, Thompson WD, Evans AS: Methods in Observational Epidemiology. New York, Oxford University Press, 1986, pp 293–297
[84]84. Davis CE, Kim H: Is triglyceride an independent risk factor for CHD? Circulation 1990;81:14
[88]88. Childs B: Introduction, in Childs B, Holtzman NA, Kazazian HH, Valle DL (eds): Molecular Genetics in Medicine. Progress in Medical Genetics, New Series, Vol 7. New York, Elsevier, 1988, Pp 1-16
[93]93. Mahley RW, Innerarity TL, Rall SC Jr, Weisbraber KH: Lipoproteins of special significance in atherosclerosis: Insights provided by studies of Type III hyperlipidemia. Ann N Y Acad Sci 1986;485:209–221
[92]92. Sane T, Nikkila EA: Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Arteriosclerosis 1987;8:217–226
[97]97. Shen MMS, Krauss RM, Lindgren FT, Forte TM: Heterogeneity of serum low density lipoproteins in normal subjects. J Lipid Res 1981;22:236–244
[99]99. Lindgren FT, Jensen LC, Hatch FT: The isolation and quantitative analysis of serum lipoproteins, In Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, Wiley Interscience, 1972, pp 181–274
[101]101. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ: Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia. J Clin Invest 1984;74:470–482
[102]102. Nichols AV, Krauss RM, Musliner TA: Nondenaturing polyacrylamide gradient gel electrophoresis, In Segrest JP, Albers JJ (eds): Methods in Enzymology, Plasma Lipoproteins. Part A. Preparation, Structure and Molecular Biology. Orlando, Fla, Academic Press, Inc, 1986, vol 41, pp 417–431
[110]110. Gianturco SH, Bradley WA: A cellular basis for the atherogenicity of triglyceride-risk lipoproteins. Atherosclerosis Rev (in press)

Sorted by citations

Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
“, risk unrelated to its impact on LDL and HDL remodeling), but this issue remains debated (16, 223, 635).”
Background
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
“Postmenopausal with HT NA NA NA NA 278 (15) 352 (18)c 326 (18)c 368 (19)b”
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Self-citation
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
Després, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodés-Cabau, J., Bertrand, O. F., & Poirier, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159228 · Cited by 1,589
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease: The Bezafibrate Infarction Prevention (BIP) Study
(2000) · Circulation · doi:10.1161/01.cir.102.1.21 · Cited by 1,273
Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins
Marenberg, M. E., RISCH, N. J., Berkman, L. F., Floderus, B., & Fairé, U. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301503 · Cited by 1,256
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Self-citation
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
“For decades, triglycerides (TG) have been considered a putative risk factor for atherosclerotic cardiovascular disease (ASCVD).(1,2) Despite mounting evidence from population and genetic studies, con-”
Background
Untitled work
Greenland (2000) · doi:10.1161/01.cir.101.1.e16 · Cited by 924
Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 908
Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome
Coughlin, S. R. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.02.021 · Cited by 848
Health implications of obesity
Pi-Sunyer, F. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.6.1595s · Cited by 807
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 781
Insulin resistance and cigarette smoking
Facchini, F. S., Hollenbeck, C. B., Jeppesen, J., Chen, Y. I., & Reaven, G. M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90730-q · Cited by 723
Triglyceride Concentration and Ischemic Heart Disease
Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 678
“may not provide an appropriate representation of underlying biological processes.(1) Finally, adding to the complexity, some”
Background
Primary Prevention of Coronary Heart Disease: Guidance From Framingham: A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609
The Role of Functional Foods, Nutraceuticals, and Food Supplements in Intestinal Health
Čenčič, A., & Chingwaru, W. (2010) · Nutrients · doi:10.3390/nu2060611 · Cited by 591
“As a result, treatment of hypercholesterolemia has focused on increasing fecal excretion of cholesterol and bile acids, and reducing hepatic cholesterol synthesis through diet modification among the few optional strategies available [25,26].”
Background
Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies
Lampe, J. W. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.475s · Cited by 786
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk
Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90129-5 · Cited by 525
Free radical-lipid interactions and their pathological consequences
Rice-Evans, C. A., & Burdon, R. H. (1993) · Progress in Lipid Research · doi:10.1016/0163-7827(93)90006-i · Cited by 515
Postprandial lipoproteins and progression of coronary atherosclerosis
Karpe, F., Steiner, G. A., Uffelman, K. D., Olivecrona, T., & Hamsten, A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90085-x · Cited by 485
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
Dallongeville, J., Lussier‐Cacan, S., & Davignon, J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41611-6 · Cited by 444
Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease
Lamarche, B. (1998) · JAMA · doi:10.1001/jama.279.24.1955 · Cited by 418
In vivo regulation of lipolysis in humans.
Coppack, S. W., Jensen, M. D., & Miles, J. M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41207-6 · Cited by 411
Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With Hypertriglyceridemia
Bakker-Arkema, R. G. (1996) · JAMA · doi:10.1001/jama.1996.03530260042029 · Cited by 406
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations
Grundy, S. M., Pasternak, R. C., Greenland, P., Smith, S. C., & Fuster, V. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00387-3 · Cited by 403
Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol
Frick, M. H., Syvänne, M., Nieminen, M. S., Kauma, H., Majahalme, S. K., Virtanen, V., Kesäniemi, Y. A., Pasternack, A. I., & Taskinen, M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2137 · Cited by 389
High density lipoproteins and coronary heart disease
Barter, P. J., & Rye, K.-A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05675-0 · Cited by 377
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Circulation · doi:10.1161/01.cir.0000145615.33955.83 · Cited by 358
Lipoprotein Metabolism and Renal Failure
Attman, P., Samuelsson, O. G., & Alaupovic, P. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80030-8 · Cited by 356
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
Grundy, S. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 353
Epidemiology of triglycerides: A view from Framingham
Castelli, W. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91083-g · Cited by 346
Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo: Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media
Nordestgaard, B. G., Wootton, R., & Lewis, B. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.534 · Cited by 334
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315
Obesity and Disease Management: Effects of Weight Loss on Comorbid Conditions
Anderson, J. W., & Konz, E. C. (2001) · Obesity Research · doi:10.1038/oby.2001.138 · Cited by 330
“The independent effects of serum triglycerides are controversial and were not summarized (23).”
Background
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
Grundy, S. M., Arai, H., Barter, P. J., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A. M., Davidson, M. H., Genest, J. J., Kesäniemi, Y. A., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 334
“The total cholesterol/HDL-C ratio adds nothing to global risk assessment because the ratio is already part of the latter.”
Background
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
Hodis, H. N., Mack, W. J., Azen, S. P., Alaupovic, P., Pogoda, J. M., LaBree, L., Hemphill, L., Kramsch, D. M., & Blankenhorn, D. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.42 · Cited by 321
HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study
Després, J., Lemieux, I., Dagenais, G. R., Cantin, B., & Lamarche, B. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00603-1 · Cited by 316
“However, we need to keep in mind that the biological variability of a fasting triglyceride measurement (that is variation from one day to another) is notoriously greater than for HDL-cholesterol, the latter being a major contributor of the variation in the cholesterol/HDL-cholesterol ratio [20].”
BackgroundResultInfluential
High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia
Kawagishi, T., Nishizawà, Y., Konishi, T., Kawasaki, K., Emoto, M., Shoji, T., Tabata, T., Inoue, T., & Morii, H. (1995) · Kidney International · doi:10.1038/ki.1995.356 · Cited by 310
Saturated fats: what dietary intake?
German, J. B., & Dillard, C. J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.550 · Cited by 293
Atorvastatin
Lea, A. P., & McTavish, D. (1997) · Drugs · doi:10.2165/00003495-199753050-00011 · Cited by 292
The health consequences of smoking: Cardiovascular Diseases
McBride, P. E. (1992) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30356-x · Cited by 291
Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women
Coresh, J., Kwiterovich, P., Smith, H., & Bachorik, P. S. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35731-x · Cited by 290
Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease
Liu, J., Sempos, C. T., Donahue, R. P., Dorn, J., Trevisan, M., & Grundy, S. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.032 · Cited by 277
Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease
Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1114 · Cited by 274
Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
Mahley, R. W., Palaoğlu, K. E., Atak, Z., Dawson-Pepin, J., Langlois, A. M., Cheung, V., Onat, H., Fulks, P., Mahley, L. L., & Vakar, F. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40067-7 · Cited by 268
Comorbidities of overweight and obesity: current evidence and research issues
Pi-Sunyer, X. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199911001-00019 · Cited by 274
Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus
Syvänne, M., & Taskinen, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90024-6 · Cited by 266
Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study.
Austin, M. A., McKnight, B., Edwards, K. L., Bradley, C. M., McNeely, M. J., Psaty, B. M., Brunzell, J. D., & Motulsky, A. G. (2000) · Circulation · doi:10.1161/01.cir.101.24.2777 · Cited by 255
Self-citation
Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins
Zilversmit, D. B. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.153 · Cited by 260
“Increased serum triglycerides plus a low HDL-cholesterol have been”
BackgroundResultInfluential
Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men
Denke, M. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.9.1093 · Cited by 261
Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
Miller, D. B., & Spence, J. D. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834020-00003 · Cited by 259
Alimentary Lipemia, Postprandial Triglyceride-Rich Lipoproteins, and Common Carotid Intima-Media Thickness in Healthy, Middle-Aged Men
Boquist, S., Ruotolo, G., Tang, R., Björkegren, J., Bond, M. G., Fairé, U. D., Karpe, F., & Hamsten, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.723 · Cited by 258
Intestinal lipid absorption and transport
Cam, T. P. (2001) · Frontiers in bioscience · doi:10.2741/phan · Cited by 252
Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251
“Large observational studies, and meta-analyses thereof, have shown that elevated triglycerides are associatedwith increased risk of cardiovascular disease (Austin, 1991; Hokanson & Austin, 1996; Nordestgaard et al., 2007; Freiberg et al., 2008; Di Angelantonio et al., 2009; Chapman et al., 2011; Varbo et al., 2011b);…”
Background
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
Barter, P. J., Kastelein, J. J. P., Nunn, A. V. W., & Hobbs, R. F. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00006-6 · Cited by 242
“Since both TG-rich lipoproteins [58] and small, dense LDLs [59] may be atherogenic, an inverse relationship between the concentration of HDL-C and the development CHD may reflect no more than an increase in the levels of TGrich lipoproteins or small dense LDLs.”
Background
Relation Between Insulin Resistance, Hyperinsulinemia, Postheparin Plasma Lipoprotein Lipase Activity, and Postprandial Lipemia
Jeppesen, J., Hollenbeck, C. B., Zhou, M., Coulston, A. M., Jones, C., Chen, Y. I., & Reaven, G. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.3.320 · Cited by 236
Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women
Jeppesen, J., Schaaf, P., Jones, C., Zhou, M., Chen, Y., & Reaven, G. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.1027 · Cited by 232
Transient Triglyceridemia Decreases Vascular Reactivity in Young, Healthy Men Without Risk Factors for Coronary Heart Disease
Lundman, P., Eriksson, M. J., Schenck-Gustafsson, K. G., Karpe, F., & Tornvall, P. (1997) · Circulation · doi:10.1161/01.cir.96.10.3266 · Cited by 234
Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men
Adler, A., & Holub, B. J. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.445 · Cited by 229
Diagnostic Criteria for Dyslipidemia - Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
Teramoto, T., Sasaki, J., Ueshima, H., Egusa, G., Kinoshita, M., Shimamoto, K., Daida, H., Biro, S., Hirobe, K., Funahashi, T., et al. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e537 · Cited by 238
An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.
Dammerman, M., Sandkuijl, L. A., Halaas, J. L., Chung, W. K., & Breslow, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4562 · Cited by 226
Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals
Hanefeld, M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00059-3 · Cited by 222
“Hypertriglyceridemia may act more indirectly via modification of LDL and HDL composition [39].”
Background
The fourth Musketeer ? from Alexandre Dumas to Claude Bernard
Reaven, G. M. (1995) · Diabetologia · doi:10.1007/s001250050247 · Cited by 219
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1990 · Cited by 215
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study.
Brown, S. A., Hutchinson, R. G., Morrisett, J. D., Boerwinkle, E., DAVIS, C. E., Gotto, A. M., & Patsch, W. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.8.1139 · Cited by 207
Hyperinsulinemia in a normal population as a predictor of non—insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The barilla factory revisited
Zavaroni, I., Bonini, L., Gasparini, P., Barilli, A. L., Zuccarelli, A., Dall’Aglio, E., Delsignore, R., & Reaven, G. M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90195-6 · Cited by 207
Very Low-Density Lipoprotein Activates Nuclear Factor-κB in Endothelial Cells
Dichtl, W., Nilsson, L., Gonçalves, I., Ares, M. P. S., Banfi, C., Calara, F. B., Hamsten, A., Eriksson, P. O., & Nilsson, J. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1085 · Cited by 199
Prevalence of and Risk Factors Associated with Carotid Artery Stenosis: The Tromsø Study
Mathiesen, E. B., Joakimsen, O., & Bønaa, K. H. (2001) · Cerebrovascular Diseases · doi:10.1159/000047680 · Cited by 197
Current and future treatment of hyperlipidemia: the role of statins.
Farnier, M., & Davignon, J. (1998) · American Journal of Cardiology · doi:10.1016/s0002-9149(98)00423-8 · Cited by 196
Echo-Lucency of Computerized Ultrasound Images of Carotid Atherosclerotic Plaques Are Associated With Increased Levels of Triglyceride-Rich Lipoproteins as Well as Increased Plaque Lipid Content
Grønholdt, M.-L. M., Nordestgaard, B. G., Wiebe, B. M., Wilhjelm, J. E., & Sillesen, H. H. (1998) · Circulation · doi:10.1161/01.cir.97.1.34 · Cited by 188
Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal Women
Darling, G. M., Johns, J., McCloud, P., & Davis, S. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370903 · Cited by 189
Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity.
Freeman, D. J., Griffin, B. A., HOLMES, A., Lindsay, G. M., Gaffney, D. F., Packard, C. J., & Shepherd, J. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.336 · Cited by 188
“21 g/mL), and it is the former that is particularly associated with protection from coronary artery disease.(4) The strong inverse correlation between triglyceride concentration and HDL concentration(5) and HDL size in normal individuals(6) is thought to be due to triglyceride transfer from very-low-density lipoprotei…”
Background
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
Hata, Y., Mabuchi, H., Saitō, Y., Itakura, H., Egusa, G., Ito, H., Teramoto, T., Tsushima, M., Tada, N., Oikawa, S., et al. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.1 · Cited by 188
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
Bjorkegren, J., Packard, C. J., Hamsten, A., Bedford, D., Caslake, M., Foster, L., Shepherd, J., Stewart, P., & Karpe, F. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37637-9 · Cited by 187
Association of Remnant Lipoprotein Levels With Impairment of Endothelium-Dependent Vasomotor Function in Human Coronary Arteries
Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Nakagawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., et al. (1998) · Circulation · doi:10.1161/01.cir.97.25.2519 · Cited by 187
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia
Dart, A. M., Jerums, G., Nicholson, G. C., dʼEmden, M. C., Hamilton‐Craig, I. R., Tallis, G. A., Best, J. D., West, M., SULLIVAN, D. R., Braes, P., et al. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00280-4 · Cited by 186
Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
Shoji, T., Nishizawa, Y., Kawagishi, T., Kawasaki, K., Taniwaki, H., Tabata, T., Inoue, T., & Morii, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971277 · Cited by 183
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease
Reaven, G. M., & Laws, A. (1994) · Diabetologia · doi:10.1007/bf00400953 · Cited by 180
Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins
Pownall, H. J., Brauchi, D., Kilinç, C., Osmundsen, K., Pao, Q., Payton-Ross, C., Gotto, A. M., & Ballantyne, C. M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00301-3 · Cited by 179
Blood lipid response to 20 weeks of supervised exercise in a large biracial population: The HERITAGE family study
Leon, A. S., Rice, T., Mandel, S., Despres, J.-P., Bergeron, J., Gagnon, J., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80018-9 · Cited by 176
Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)
Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80760-7 · Cited by 170
The role of fibric acids in atherosclerosis
Fruchart, J., Staels, B., & Duriez, P. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0015-x · Cited by 171
Excess body weight. An under-recognized contributor to dyslipidemia in white American women
Denke, M. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.4.401 · Cited by 166
Fibrate‐induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
Broeders, N., Knoop, C., Antoine, M., Tielemans, C., & Abramowicz, D. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.12.1993 · Cited by 163
“To better characterize this side-effect, we important risk factors for the development of atherofirst reviewed the charts of 27 patients from our sclerosis [1–3].”
Background
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia
Wiklund, O., Angelin, B., Bergman, M., Berglund, L., Bondjers, G., Carlsson, A., LINDÉN, T., Miettinen, T. A., Ödman, B., Olofsson, S., et al. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90114-5 · Cited by 163
Familial Resemblance of Plasma Lipids, Lipoproteins and Postheparin Lipoprotein and Hepatic Lipases in the HERITAGE Family Study
Përusse, L., Rice, T., Després, J., Bergeron, J., Province, M. A., Gagnon, J., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3263 · Cited by 155
Serum calcium: A new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years
Lind, L., Skarfors, E., Berglund, L., Lithell, H., & Ljunghall, S. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00104-2 · Cited by 153
Changes in triglyceride levels and risk for coronary heart disease in young men.
Tirosh, A., Rudich, A., Shochat, T., Tekes-Manova, D., Israeli, E., Henkin, Y., Kochba, I., & Shai, I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00007 · Cited by 151
Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period
Heath, R. B., Karpe, F., Milne, R. W., Burdge, G. C., Wootton, S. A., & Frayn, K. N. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300167-jlr200 · Cited by 151
Triglycerides as vascular risk factors: new epidemiologic insights.
Kannel, W. B., & Vasan, R. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832c1284 · Cited by 149
Triglyceride-Rich Lipoprotein Remnant Particles and Risk of Atherosclerosis
Hodis, H. N. (1999) · Circulation · doi:10.1161/01.cir.99.22.2852 · Cited by 149
The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.
Tsutsumi, K., Inoue, Y., Shima, A., Iwasaki, K., Kawamura, M., & Murase, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116582 · Cited by 149
“Recently there has been increasing evidence of an association between triglycerides and increased risk of coronary heart disease (1).”
Background
Heterozygous Lipoprotein Lipase Deficiency: Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease
Nordestgaard, B. G., Abildgaard, S., Wittrup, H. H., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1737 · Cited by 146
Structural models of human apolipoprotein A-I
Brouillette, C. G., & Anantharamaiah, G. M. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00018-8 · Cited by 146
Remnant Cholesterol and Triglyceride-Rich Lipoproteins in Atherosclerosis Progression and Cardiovascular Disease
Varbo, A., & Nordestgaard, B. G. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308305 · Cited by 147

Authors: Austin, M. A.
Affiliations: University of Washington (US)
Corresponding author: Austin, M A
Venue: Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1991-01
Volume: 11
Issue: 1
Pages: 2-14
ISSN: 1049-8834 (ISSN-L)
DOI: 10.1161/01.atv.11.1.2
OpenAlex: W2155238815
Cited by: 697
References: 98
Citations by year: 2026: 2 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 13 · 2012: 8
FWCI: 15.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (7r29hl038760-03)
National Heart, Lung, and Blood Institute (HL38760, P01HL030086, HL3-0086)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: plasma triglycerides, coronary artery disease, cardiovascular risk factors, hypertriglyceridemia, familial hypertriglyceridemia, small dense LDL, HDL cholesterol, genetic susceptibility, primary prevention, lipid-lowering intervention
MeSH terms: Coronary Disease, Female, Humans, Male, Pedigree, Triglycerides, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma triglyceride and coronary heart disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks